SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-19-022632
Filing Date
2019-04-19
Accepted
2019-04-19 17:00:54
Documents
4
Period of Report
2019-04-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A a19-2580_1pre14a.htm PRE 14A 1037938
2 GRAPHIC g25801bci001.gif GRAPHIC 10947
3 GRAPHIC g25801bci002.jpg GRAPHIC 1962
4 GRAPHIC g25801bci003.gif GRAPHIC 2989
  Complete submission text file 0001104659-19-022632.txt   1061276
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35619 | Film No.: 19758232
SIC: 2834 Pharmaceutical Preparations